Earnings Feed
Start Free
Orchestra BioMed Holdings, Inc.·4

Jun 12, 4:16 PM ET

Taylor Andrew Lawrence 4

Research Summary

AI-generated summary

Updated

Orchestra BioMed (OBIO) CFO Taylor Lawrence Withholds 36,352 Shares

What Happened
Taylor Andrew Lawrence, Chief Financial Officer of Orchestra BioMed (OBIO), had 36,352 shares withheld by the company to satisfy tax withholding obligations related to the vesting of restricted stock units (RSUs). The withholding was calculated at $4.02 per share for a notional value of approximately $146,135. No shares were sold on the open market as part of this transaction.

Key Details

  • Transaction date: 2026-06-10; Filing date: 2026-06-12 (timely Form 4 filing).
  • Withheld shares: 36,352 at $4.02 per share; total value ≈ $146,135.
  • Transaction code: F — withholding to satisfy tax withholding obligations for vested RSUs.
  • Shares owned after transaction: Not specified in the provided filing excerpt.
  • Footnote: Issuer withheld shares to satisfy tax withholding; explicitly states no market sale occurred.

Context
This was a tax-withholding event tied to RSU vesting (not an open-market sale or purchase). Such withholding is a routine administrative step and does not necessarily indicate any change in insider sentiment. The filing appears timely under Section 16 reporting rules.